T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation

T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of preference for numerous malignant and non-malignant hemopathies. The outcome of this approach is significantly hampered by not only graft-versus-host disease (GvHD), but also infections and relapses that may occur because...

Full description

Bibliographic Details
Main Authors: Pierre Gaudeaux, Ranjita Devi Moirangthem, Aurélie Bauquet, Laura Simons, Akshay Joshi, Marina Cavazzana, Olivier Nègre, Shabi Soheili, Isabelle André
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
allogeneic hematopoietic stem cell transplantation
T-cells
immune reconstitution
T-cell progenitors
immunotherapy
thymus
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.956919/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.956919/full

Similar Items